stockportfolio.pro
Bio-Rad Laboratories, Inc. Net Income 2008–2025
Bio-Rad Laboratories, Inc. (BIO) annual net income by fiscal year, computed from SEC filings. Compound growth +13.4%/yr over 17 years.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $759.90M | 29.4% | +141.2% |
| FY 2024 | $-1.84B | -71.9% | -189.4% |
| FY 2023 | $-637.32M | -23.9% | +82.4% |
| FY 2022 | $-3.63B | -129.5% | -185.3% |
| FY 2021 | $4.25B | 145.6% | +11.5% |
| FY 2020 | $3.81B | 149.8% | +116.9% |
| FY 2019 | $1.76B | 76.1% | +381.0% |
| FY 2018 | $365.61M | 16.0% | +199.1% |
| FY 2017 | $122.25M | 5.7% | +370.2% |
| FY 2016 | $26.00M | 1.3% | -76.2% |
| FY 2015 | $109.24M | 5.4% | +23.0% |
| FY 2014 | $88.84M | 4.1% | +14.2% |
| FY 2013 | $77.79M | 3.6% | -53.0% |
| FY 2012 | $165.48M | 8.0% | -7.6% |
| FY 2011 | $179.01M | 8.6% | -3.5% |
| FY 2010 | $185.49M | 9.6% | +28.3% |
| FY 2009 | $144.62M | 8.1% | +61.6% |
| FY 2008 | $89.51M | 5.1% | — |
Source: Bio-Rad Laboratories, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Bio-Rad Laboratories, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBio-Rad Laboratories, Inc. — frequently asked questions
What is Bio-Rad Laboratories, Inc.'s net income?
Bio-Rad Laboratories, Inc. (BIO) reported net income of $759.90M for fiscal year 2025, per its SEC filings.
How has Bio-Rad Laboratories, Inc.'s net income changed over time?
Between fiscal 2008 and 2025, BIO's net income grew at roughly 13.4% per year (compound annual rate), from $89.51M to $759.90M.
Where does this data come from?
Figures are computed from Bio-Rad Laboratories, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.